“We … are currently evaluating resource allocation, including pipeline prioritization and a workforce reorganization,” CFO Kimi Iguchi said in an Aug. 7 investor call.
The drug, Zurzuvae (zuranolone), is the first FDA-approved drug to treat postpartum depression, but Sage and its partner Biogen have not yet announced the list price.
Sage did not immediately reply to Becker’s request for details on how many jobs might be affected, and no WARN notices have been filed in states with Sage locations, Massachusetts and North Carolina.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
